| Heart disease and stroke statistics—2014 update: a report from the American Heart Association AS Go, D Mozaffarian, VL Roger, EJ Benjamin, JD Berry, MJ Blaha, S Dai, ... circulation 129 (3), e28-e292, 2014 | 57585* | 2014 |
| Heart disease and stroke statistics—2016 update: a report from the American Heart Association D Mozaffarian, EJ Benjamin, AS Go, DK Arnett, MJ Blaha, M Cushman, ... circulation 133 (4), e38-e360, 2016 | 28829* | 2016 |
| Third universal definition of myocardial infarction K Thygesen, JS Alpert, AS Jaffe, ML Simoons, BR Chaitman, HD White circulation 126 (16), 2020-2035, 2012 | 18517* | 2012 |
| Dabigatran versus warfarin in patients with atrial fibrillation SJ Connolly, MD Ezekowitz, S Yusuf, J Eikelboom, J Oldgren, A Parekh, ... New England journal of medicine 361 (12), 1139-1151, 2009 | 14694 | 2009 |
| Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Antithrombotic Trialists' Collaboration Bmj 324 (7329), 71-86, 2002 | 13725* | 2002 |
| 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial … B Ibanez, S James, S Agewall, MJ Antunes, C Bucciarelli-Ducci, H Bueno, ... European heart journal 39 (2), 119-177, 2018 | 12556 | 2018 |
| Apixaban versus warfarin in patients with atrial fibrillation CB Granger, JH Alexander, JJV McMurray, RD Lopes, EM Hylek, ... New England Journal of Medicine 365 (11), 981-992, 2011 | 11283 | 2011 |
| Ticagrelor versus clopidogrel in patients with acute coronary syndromes L Wallentin, RC Becker, A Budaj, CP Cannon, H Emanuelsson, C Held, ... New England Journal of Medicine 361 (11), 1045-1057, 2009 | 8713 | 2009 |
| Heart disease and stroke statistics 2005 update American Heart Association http://www. americanheart. org/statistics/, 2005 | 8600* | 2005 |
| ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation … Authors/Task Force Members, PG Steg, SK James, D Atar, LP Badano, ... European heart journal 33 (20), 2569-2619, 2012 | 6947 | 2012 |
| Discovery and refinement of loci associated with lipid levels CJ Willer, EM Schmidt, S Sengupta, GM Peloso, S Gustafsson, S Kanoni, ... Nature genetics 45 (11), 1274, 2013 | 3049* | 2013 |
| Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation … JP Bassand, CW Hamm, D Ardissino, E Boersma, A Budaj, ... European heart journal 28 (13), 1598-1660, 2007 | 2539 | 2007 |
| Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease B Lindahl, H Toss, A Siegbahn, P Venge, L Wallentin New England Journal of Medicine 343 (16), 1139-1147, 2000 | 1819 | 2000 |
| Large-scale association analysis identifies new risk loci for coronary artery disease CARDIoGRAMplusC4D Consortium, P Deloukas, S Kanoni, C Willenborg, ... Nature genetics 45 (1), 25-33, 2013 | 1780 | 2013 |
| Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden B Lagerqvist, SK James, U Stenestrand, J Lindbäck, T Nilsson, ... New England Journal of Medicine 356 (10), 1009-1019, 2007 | 1618 | 2007 |
| Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation M Bertrand, M Simoons, K Fox, L Wallentin, C Hamm, P de Feyter, ... European heart journal, 2002 | 1607 | 2002 |
| Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term … JW Eikelboom, L Wallentin, SJ Connolly, M Ezekowitz, JS Healey, ... Circulation 123 (21), 2363-2372, 2011 | 1558 | 2011 |
| Comparison of fondaparinux and enoxaparin in acute coronary syndromes Fifth Organization to Assess Strategies in Acute Ischemic Syndromes ... New England Journal of Medicine 354 (14), 1464-1476, 2006 | 1508 | 2006 |
| Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials E Boersma, RA Harrington, DJ Moliterno, H White, P Théroux, ... The Lancet 359 (9302), 189-198, 2002 | 1423 | 2002 |
| Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis … L Wallentin, S Yusuf, MD Ezekowitz, M Alings, M Flather, MG Franzosi, ... The Lancet 376 (9745), 975-983, 2010 | 1355* | 2010 |
